Idiopathic pulmonary fibrosis: is it a familial disease?

被引:18
|
作者
Allam, J. Shirine
Limper, Andrew H.
机构
[1] Mayo Clin, Coll Med, Dept Internal Med, Div Pulm & Crit Care, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Thorac Dis Res Unit, Rochester, MN 55905 USA
关键词
familial interstitial pulmonary fibrosis; genetics; interstitial pulmonary fibrosis; surfactant proteins;
D O I
10.1097/01.mcp.0000239546.24831.61
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose of review Idiopathic pulmonary fibrosis is a progressively fatal interstitial lung disease associated with pathological findings of usual interstitial, pneumonia. Its pathognesis is unknown, and there are no proven effective therapies Familial cases account for 0.5-2% of idiopathic pulmonary fibrosis. Familial idiopathic pulmonary fibrosis occurs as an autosomal dominant disorder with variable penetrance. The clinical characteristics of familial idiopathic pulmonary fibrosis are indistinguishable from sporadic idiopathic pulmonary fibrosis. These marked similarities support the hypothesis there may, in part, be a genetic basis for idiopathic pulmonary fibrosis. Recent findings Many investigations have evaluated genetic polymorphisms and idiopathic pulmonar fibrosis. Candidate genes include and surfactant protein genes. To date, no gene has been consistently identified to be-associated with idiopathic pulmonary fibrosis. Recent studies in familial, idiopathic pulmonary fibrosis have demonstrated a strong association with surfactant protein C gene mutations in one large kindred. Summary The pathogenesis of both idiopathic pulmonary fibrbsis and familial idiopathic pulmonary fibrosis remains unclear. A consistent genetic basis has not yet been demonstrated in all cases. Other factors, including variable gene expression, co-carriage of other modifying genes and environmental stimuli, particularly cigarette smoke, significantly contribute to disease expression.
引用
收藏
页码:312 / 317
页数:6
相关论文
共 50 条
  • [31] The Eyes Have It-for Idiopathic Pulmonary Fibrosis: a Preliminary Observation
    Pleasants, Roy A.
    Bedoya, Armando D.
    Boggan, Joel M.
    Welty-Wolf, Karen
    Tighe, Robert M.
    PULMONARY THERAPY, 2022, 8 (03) : 327 - 331
  • [32] Investigation of telomere related gene mutations in idiopathic pulmonary fibrosis
    Halime Yildirim
    Pinar Yildiz
    Ender Coskunpinar
    Molecular Biology Reports, 2020, 47 : 7851 - 7860
  • [33] Percutaneous Cryoablation for Lung Cancer Patients with Idiopathic Pulmonary Fibrosis
    Ohtsuka, T.
    Masai, K.
    Kaseda, K.
    Hishida, T.
    Nakatsuka, S.
    Asamura, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1978 - S1978
  • [34] Investigation of telomere related gene mutations in idiopathic pulmonary fibrosis
    Yildirim, Halime
    Yildiz, Pinar
    Coskunpinar, Ender
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (10) : 7851 - 7860
  • [35] Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis
    Michalski, Jacob E.
    Schwartz, David A.
    JOURNAL OF INFLAMMATION RESEARCH, 2020, 13 : 1305 - 1317
  • [36] Analysis of candidate genes of phenotypic expression in idiopathic pulmonary fibrosis
    Mota, Patricia Caetano
    Ferreira, Antonio Carlos
    Vasconcelos, Carlos Daniel
    Soares, Miguel Luz
    Melo, Natalia
    Pereira, Jose Miguel
    Moura, Conceicao Souto
    Morais, Antonio
    Marques, Jose Agostinho
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [37] The Microbiome in Cystic Fibrosis Pulmonary Disease
    Francoise, Alice
    Hery-Arnaud, Genevieve
    GENES, 2020, 11 (05)
  • [38] Rare surfactant-related variants in familial and sporadic pulmonary fibrosis
    Sutton, Rachel M.
    Bittar, Humberto Trejo
    Sullivan, Daniel, I
    Silva, Agustin Gil
    Bahudhanapati, Harinath
    Parikh, Anishka H.
    Zhang, Yingze
    Gibson, Kevin
    McDyer, John F.
    Kass, Daniel J.
    Alder, Jonathan K.
    HUMAN MUTATION, 2022, 43 (12) : 2091 - 2101
  • [39] Molecular classification of idiopathic pulmonary fibrosis: Personalized medicine, genetics and biomarkers
    Hambly, Nathan
    Shimbori, Chiko
    Kolb, Martin
    RESPIROLOGY, 2015, 20 (07) : 1010 - 1022
  • [40] Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
    Allen, Richard J.
    Guillen-Guio, Beatriz
    Oldham, Justin M.
    Ma, Shwu-Fan
    Dressen, Amy
    Paynton, Megan L.
    Kraven, Luke M.
    Obeidat, Ma'en
    Li, Xuan
    Ng, Michael
    Braybrooke, Rebecca
    Molina-Molina, Maria
    Hobbs, Brian D.
    Putman, Rachel K.
    Sakornsakolpat, Phuwanat
    Booth, Helen L.
    Fahy, William A.
    Hart, Simon P.
    Hill, Mike R.
    Hirani, Nik
    Hubbard, Richard B.
    McAnulty, Robin J.
    Millar, Ann B.
    Navaratnam, Vidyia
    Oballa, Eunice
    Parfrey, Helen
    Saini, Gauri
    Whyte, Moira K. B.
    Zhang, Yingze
    Kaminski, Naftali
    Adegunsoye, Ayodeji
    Strek, Mary E.
    Neighbors, Margaret
    Sheng, Xuting R.
    Gudmundsson, Gunnar
    Gudnason, Vilmundur
    Hatabu, Hiroto
    Lederer, David J.
    Manichaikul, Ani
    Newell, John D., Jr.
    O'Connor, George T.
    Ortega, Victor E.
    Xu, Hanfei
    Fingerlin, Tasha E.
    Bosse, Yohan
    Hao, Ke
    Joubert, Philippe
    Nickle, David C.
    Sin, Don D.
    Timens, Wim
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (05) : 564 - 574